摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Chloro-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane | 167895-92-3

中文名称
——
中文别名
——
英文名称
2-Chloro-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane
英文别名
5-Tert-butyl-2-chloro-3-methyl-1,3,2-oxazaphosphinane
2-Chloro-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane化学式
CAS
167895-92-3
化学式
C8H17ClNOP
mdl
——
分子量
209.656
InChiKey
LMFZQGHIUXJWRV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    六氟异丙醇2-Chloro-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane三乙胺 作用下, 以 乙醚 为溶剂, 反应 3.0h, 以91%的产率得到cis-2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane
    参考文献:
    名称:
    Study of the Conformational Equilibria of 2-Z-3-Methyl-1,3,2-oxazaphosphorinanes. Steric and Stereoelectronic Influences on the Orientation of the Me2N Substituent on Three-Coordinate Phosphorus
    摘要:
    The conformations of a series of 1,3,2-oxazaphosphorinanes containing three-coordinate phosphorus, 1-9, have been determined by the use of H-1, P-31, and C-13 NMR spectroscopy. The rings were substituted at ring nitrogen, N(3), with a methyl group to compare its effect on conformational energies with those of 1,3,2-oxazaphosphorinanes reported earlier that featured a larger substituent at N(3), Ph or i-Pr. Quite expectedly, like those rings previously studied with Ph or i-Pr at N(3), a MeO or (CF3)(2)CHO substituent at phosphorus has a strong preference to be axial on a chair-form ring, 1-4, cis-7, and cis-8, or pseudoaxial on a ring in a twist/boat conformation, trans-7. However, when Me(2)N is attached to phosphorus, the newly studied N(3)Me rings display a chair-chair conformational equilibrium, 10 reversible arrow 11, with the Me(2)N equatorial ring, 11, mildly dominant (58/42, 5; 65/35, 6). This contrasts with ratios of 17/83 and 20/80 for the corresponding N(3)Ph analogs, A, and 23/77 for the N(S)-i-Pr compound, B. The observed change in the free energy of the equilibrium 10 reversible arrow 11, 1.2-1.3 kcal/mol, is ascribed to the dominant influence of a decrease in repulsion experienced in conformation 11 between the equatorial Me(2)NP and the smaller Me at N(3)(Me(2)N(eq)/N(3)Me destabilization) compared to that experienced with the N(3)Ph and N(3)-i-Pr analogs. This steric influence of N(3) substituents on the equilibrium 10 reversible arrow 11 is opposite to that found for four-coordinate phosphorus containing 1,3,2-oxazaphosphorinanes in which Me(2)NP(ax/N(3)Ph repulsions that destabilize 10 appear to be dominant.
    DOI:
    10.1021/jo00120a020
  • 作为产物:
    描述:
    N-methyl-2-(hydroxymethyl)-3,3-dimethylbutylamine三乙胺三氯化磷 作用下, 以 四氢呋喃 为溶剂, 反应 48.0h, 以57%的产率得到2-Chloro-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane
    参考文献:
    名称:
    Study of the Conformational Equilibria of 2-Z-3-Methyl-1,3,2-oxazaphosphorinanes. Steric and Stereoelectronic Influences on the Orientation of the Me2N Substituent on Three-Coordinate Phosphorus
    摘要:
    The conformations of a series of 1,3,2-oxazaphosphorinanes containing three-coordinate phosphorus, 1-9, have been determined by the use of H-1, P-31, and C-13 NMR spectroscopy. The rings were substituted at ring nitrogen, N(3), with a methyl group to compare its effect on conformational energies with those of 1,3,2-oxazaphosphorinanes reported earlier that featured a larger substituent at N(3), Ph or i-Pr. Quite expectedly, like those rings previously studied with Ph or i-Pr at N(3), a MeO or (CF3)(2)CHO substituent at phosphorus has a strong preference to be axial on a chair-form ring, 1-4, cis-7, and cis-8, or pseudoaxial on a ring in a twist/boat conformation, trans-7. However, when Me(2)N is attached to phosphorus, the newly studied N(3)Me rings display a chair-chair conformational equilibrium, 10 reversible arrow 11, with the Me(2)N equatorial ring, 11, mildly dominant (58/42, 5; 65/35, 6). This contrasts with ratios of 17/83 and 20/80 for the corresponding N(3)Ph analogs, A, and 23/77 for the N(S)-i-Pr compound, B. The observed change in the free energy of the equilibrium 10 reversible arrow 11, 1.2-1.3 kcal/mol, is ascribed to the dominant influence of a decrease in repulsion experienced in conformation 11 between the equatorial Me(2)NP and the smaller Me at N(3)(Me(2)N(eq)/N(3)Me destabilization) compared to that experienced with the N(3)Ph and N(3)-i-Pr analogs. This steric influence of N(3) substituents on the equilibrium 10 reversible arrow 11 is opposite to that found for four-coordinate phosphorus containing 1,3,2-oxazaphosphorinanes in which Me(2)NP(ax/N(3)Ph repulsions that destabilize 10 appear to be dominant.
    DOI:
    10.1021/jo00120a020
点击查看最新优质反应信息

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (S)-2-Chloro-4-isobutyl-[1,3,2]oxazaphospholidine 2-sulfide (SCRP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-Chlor-1-(β-chlorethylamino)-1,3,2-azaoxaphosphorinan (SCSP)-2-anilino-3-(α-methylbenzyl)-1,3,2λ5-oxazaphosphorinane 2-oxide 2-[4-(2-Piperidin-1-yl-ethyl)-piperazin-1-yl]-[1,3,2]oxazaphosphinane 2-oxide (5-tert-Butyl-3-phenyl-[1,3,2]oxazaphosphinan-2-yl)-dimethyl-amine 4-Hydroperoxyisophosphamid-6-14C (E)-3-tert-butyl-6,6-dimethyl-2-oxo-[2'-((E)-2-butenyloxy)-1'-butenyl]-1,3,2-oxazaphosphorinane trichloroethyl cyclophosphoramidate 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-propylsulfanyl)-[1,3,2]oxazaphosphinane 2-oxide 2(S)--3-<(S)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 3-sec-Butyl-2-(2-chloro-ethylsulfanyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide 3-sec-Butyl-2-(2-chloro-1-methyl-propoxy)-[1,3,2]oxazaphosphinane 2-sulfide 2-hexadecyloxy-3-methyl-[1,3,2]oxazaphosphinane 2-oxide cis-4-Hydroperoxytrofosfamide 2(S)--3-<(R)-α-methylbenzyl>-1,3,2-oxazaphosphorinane 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine,N,N-diethyltetrahydro-3-(phenylmethyl)- 3-sec-Butyl-2-(2-chloro-1-methyl-ethoxy)-[1,3,2]oxazaphosphinane 2-sulfide cis-2-methoxy-2-thio-5-tert-butyl-1,3,2-oxazaphosphorinane 3,7,10-trimethyl-1-phenylgermatrane 2-{(2-Chloro-ethyl)-[3-(2-chloro-ethyl)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl]-amino}-ethanol 3-benzyl-2-chloro-[1,3,2]oxazaphosphinane 2-(O,O-Di-n-propyl-phosphordithiomethylen)-2-methyl-1,3-oxazolidin cis-2,3-diphenyl-2-oxo-5-tert-butyl-1,3,2λ5-oxazaphosphorinane 2-ethoxy-[1,3,2]oxazaphosphinane 2-oxide 1-Acetyl-2-diaethylamino-1,3,2-azaoxaphosphorinan 1,5-dioxa-2,6-dioxo-2,4,4,6,8,8-hexakis(pyrrolidino)cyclotetraphosphadiazadiene (2,4-dimethyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-3-yl)-phosphonous acid bis-diethylamide 2,6,6,9,12,12-hexamethyl-3,10-diphenyl-1,8-dioxa-4,11-dithia-2,9-diaza-dispiro[4.1.4.1]dodecane 2-isopropoxy-[1,3,2]oxazaphosphinane 2-sulfide 2-thioxo-2λ5-[1,3,2]oxazaphosphinan-2-ylamine (2R,3S,5S)-2,3,5-triphenyl-2-oxo-[1,4,2]-oxazaphosphinane 2-propoxy-[1,3,2]oxazaphosphinane 2-(diethylthiocarbamoylthio)-3-phenyl-1,3,2-oxazaphospholidine